To confirm whether AKT and HIF1α mediate the roles of MAP17 in HCC, a specific inhibitor of AKT (MK-2206) and specific siRNAs against HIF1α were used in MHCC-97H cells. The gene discussed is AKT1; the disease is hepatocellular carcinoma.